44.72
price down icon1.76%   -0.80
after-market Handel nachbörslich: 44.83 0.11 +0.25%
loading

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

pulisher
Jul 23, 2025

Is Tonix Pharmaceuticals Holding Corp. a good long term investmentFree Stock Market Return Analysis - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Tonix Pharmaceuticals Holding Corp. Stock Analysis and ForecastPhenomenal wealth increase - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Tonix Pharmaceuticals Holding Corp. stockExceptional portfolio growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Tonix Pharmaceuticals Holding Corp. stock priceMarket-leading growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Tonix Pharmaceuticals shares rise 2.00% premarket after launching Move Fibro Forward campaign for fibromyalgia awareness. - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Tonix Pharmaceuticals Announces the Launch of the “Move - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

Tonix Pharma Launches Move Fibro Forward Campaign - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Tonix Tackles 15-Year Fibromyalgia Treatment Void with Groundbreaking Patient Support Campaign - Stock Titan

Jul 21, 2025
pulisher
Jul 18, 2025

Tonix targets August PDUFA date for Fibromyalgia drug candidate, advances mpox vaccine strategy - Proactive financial news

Jul 18, 2025
pulisher
Jul 17, 2025

Tonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More Positive - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Are TNXP Shares Ready for a Comeback? - StocksToTrade

Jul 17, 2025
pulisher
Jul 16, 2025

Tonix Pharma Plans Sales Force for TNX-102 SL - TipRanks

Jul 16, 2025
pulisher
Jul 13, 2025

Tonix Pharmaceuticals ($TNXP) Skyrockets 284% in 2025: Earnings Catalysts.... - Investing.com India

Jul 13, 2025
pulisher
Jul 11, 2025

Tonix reports TNX-801 vaccine shows promise against mpox By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 10, 2025

Tonix Pharmaceuticals Shares Climb on Encouraging TNX-801 Vaccine Results - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Tonix Pharmaceuticals Announces Presentation of New Data on - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Tonix Pharma stock up after data for pain drug (TNXP:NASDAQ) - Seeking Alpha

Jul 10, 2025
pulisher
Jul 10, 2025

Tonix Pharmaceuticals stock rises on promising TNX-801 vaccine data By Investing.com - Investing.com India

Jul 10, 2025
pulisher
Jul 10, 2025

Tonix Pharmaceuticals stock rises on promising TNX-801 vaccine data - Investing.com Australia

Jul 10, 2025
pulisher
Jul 10, 2025

Tonix reports TNX-801 vaccine shows promise against mpox - Investing.com

Jul 10, 2025
pulisher
Jul 10, 2025

Tonix Pharma Unveils Promising TNX-801 Vaccine Findings - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

Revolutionary Mpox and Smallpox Vaccine Achieves 100,000-Fold Safety Improvement with Single-Dose Protection - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Tonix Pharmaceuticals Announces On-line Publication of - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Tonix Pharmaceuticals' TNX-102 SL: A Breakthrough in Fibromyalgia Treatment and Its Implications for Investors - AInvest

Jul 10, 2025
pulisher
Jul 09, 2025

Tonix’s fibromyalgia drug shows positive results in phase 3 trial By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 09, 2025

Tonix’s fibromyalgia drug shows positive results in phase 3 trial - Investing.com Australia

Jul 09, 2025
pulisher
Jul 09, 2025

Tonix Pharma Publishes Phase 3 Trial Results - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Tonix Pharmaceuticals Announces Publication of Positive Phase 3 RESILIENT Trial Data for TNX-102 SL in Fibromyalgia Management - Nasdaq

Jul 09, 2025
pulisher
Jul 09, 2025

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine - Yahoo Finance

Jul 09, 2025
pulisher
Jul 07, 2025

Tonix Pharmaceuticals Announces Efficacy and Safety of Single-Dose TNX-801 Vaccine Against Monkeypox - Quiver Quantitative

Jul 07, 2025
pulisher
Jul 07, 2025

Tonix Pharmaceuticals Announces Oral Presentation on Mpox - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

Breakthrough: New Single-Dose Vaccine Demonstrates 100% Protection Against Deadly Mpox Challenge - Stock Titan

Jul 07, 2025
pulisher
Jul 02, 2025

Tonix Pharmaceuticals Announces Peer-Reviewed Publication - GlobeNewswire

Jul 02, 2025
pulisher
Jul 02, 2025

Tonix reports promising cancer treatment data in animal models - Investing.com

Jul 02, 2025
pulisher
Jun 30, 2025

Tonix Pharmaceuticals Holding Corp.(NasdaqCM: TNXP) added to Russell 3000E Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Tonix Pharmaceuticals Joins Elite Russell Indexes Ahead of Major FDA Decision - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes - GlobeNewswire

Jun 30, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):